FERMT3
Basic information
Region (hg38): 11:64205926-64223896
Links
Phenotypes
GenCC
Source:
- leukocyte adhesion deficiency 3 (Strong), mode of inheritance: AR
- leukocyte adhesion deficiency 3 (Strong), mode of inheritance: AR
- leukocyte adhesion deficiency 3 (Supportive), mode of inheritance: AR
- leukocyte adhesion deficiency 3 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Leukocyte adhesion deficiency, type III | AR | Allergy/Immunology/Infectious; Hematologic | Antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; Individuals may have hematologic anomalies, and treatment (which may include RBC and platelet transfusions) may be indicated; BMT has been described | Allergy/Immunology/Infectious; Hematologic | 9312170; 12595312; 17185466; 19234460; 19064721; 20357244; 21441448 |
ClinVar
This is a list of variants' phenotypes submitted to
- Leukocyte adhesion deficiency 3 (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FERMT3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 134 | 145 | ||||
missense | 185 | 193 | ||||
nonsense | 3 | |||||
start loss | 1 | |||||
frameshift | 7 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 9 | 21 | 5 | 35 | ||
non coding | 66 | 17 | 85 | |||
Total | 6 | 5 | 199 | 205 | 27 |
Variants in FERMT3
This is a list of pathogenic ClinVar variants found in the FERMT3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-64207366-T-G | Leukocyte adhesion deficiency 3 | Uncertain significance (Mar 12, 2022) | ||
11-64207369-C-T | Leukocyte adhesion deficiency 3 | Uncertain significance (Oct 03, 2019) | ||
11-64207370-G-A | Leukocyte adhesion deficiency 3 | Likely benign (Apr 18, 2023) | ||
11-64207373-G-A | Leukocyte adhesion deficiency 3 | Likely benign (May 23, 2023) | ||
11-64207382-A-G | Leukocyte adhesion deficiency 3 | Likely benign (Feb 14, 2023) | ||
11-64207388-C-T | Leukocyte adhesion deficiency 3 | Likely benign (Jul 06, 2022) | ||
11-64207389-G-A | Leukocyte adhesion deficiency 3 | Uncertain significance (Dec 18, 2019) | ||
11-64207391-G-A | FERMT3-related disorder | Likely benign (May 23, 2019) | ||
11-64207391-G-T | Leukocyte adhesion deficiency 3 | Likely benign (Sep 07, 2022) | ||
11-64207392-G-A | Leukocyte adhesion deficiency 3 | Uncertain significance (Sep 01, 2021) | ||
11-64207398-A-G | Leukocyte adhesion deficiency 3 | Uncertain significance (Sep 27, 2022) | ||
11-64207400-C-T | Leukocyte adhesion deficiency 3 | Likely benign (Dec 16, 2023) | ||
11-64207401-G-A | Leukocyte adhesion deficiency 3 • Inborn genetic diseases | Uncertain significance (Nov 29, 2021) | ||
11-64207405-C-G | Leukocyte adhesion deficiency 3 | Uncertain significance (Aug 23, 2022) | ||
11-64207406-G-A | Leukocyte adhesion deficiency 3 | Likely benign (Oct 05, 2022) | ||
11-64207409-A-G | Leukocyte adhesion deficiency 3 | Likely benign (Apr 30, 2023) | ||
11-64207410-T-C | Leukocyte adhesion deficiency 3 | Uncertain significance (Mar 01, 2022) | ||
11-64207412-G-A | Leukocyte adhesion deficiency 3 | Pathogenic (Mar 01, 2009) | ||
11-64207416-C-G | Leukocyte adhesion deficiency 3 • Inborn genetic diseases | Uncertain significance (Jul 31, 2023) | ||
11-64207420-G-A | Leukocyte adhesion deficiency 3 • Inborn genetic diseases | Uncertain significance (Oct 17, 2022) | ||
11-64207420-G-T | Leukocyte adhesion deficiency 3 | Uncertain significance (Jul 26, 2020) | ||
11-64207438-A-G | Leukocyte adhesion deficiency 3 | Uncertain significance (Mar 03, 2022) | ||
11-64207439-G-A | Leukocyte adhesion deficiency 3 | Likely benign (Oct 14, 2023) | ||
11-64207450-C-T | Leukocyte adhesion deficiency 3 | Uncertain significance (Dec 11, 2023) | ||
11-64207451-C-T | Leukocyte adhesion deficiency 3 | Likely benign (Jun 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FERMT3 | protein_coding | protein_coding | ENST00000279227 | 14 | 17205 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000260 | 1.00 | 125696 | 0 | 52 | 125748 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.51 | 332 | 419 | 0.793 | 0.0000302 | 4296 |
Missense in Polyphen | 79 | 125.17 | 0.63115 | 1369 | ||
Synonymous | -0.262 | 188 | 183 | 1.02 | 0.0000130 | 1333 |
Loss of Function | 3.64 | 13 | 36.8 | 0.353 | 0.00000207 | 370 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000235 | 0.000235 |
Ashkenazi Jewish | 0.0000997 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000485 | 0.0000462 |
European (Non-Finnish) | 0.000295 | 0.000290 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a central role in cell adhesion in hematopoietic cells (PubMed:19234463, PubMed:26359933). Acts by activating the integrin beta-1-3 (ITGB1, ITGB2 and ITGB3) (By similarity). Required for integrin-mediated platelet adhesion and leukocyte adhesion to endothelial cells (PubMed:19234460). Required for activation of integrin beta-2 (ITGB2) in polymorphonuclear granulocytes (PMNs) (By similarity). {ECO:0000250|UniProtKB:Q8K1B8, ECO:0000269|PubMed:19234460, ECO:0000269|PubMed:19234463, ECO:0000269|PubMed:26359933}.;
- Disease
- DISEASE: Leukocyte adhesion deficiency 3 (LAD3) [MIM:612840]: A disorder characterized by recurrent bacterial infections without pus formation, leukocytosis and major bleeding disorders. {ECO:0000269|PubMed:18779414, ECO:0000269|PubMed:19064721, ECO:0000269|PubMed:19234460, ECO:0000269|PubMed:19234463, ECO:0000269|PubMed:19617577, ECO:0000269|PubMed:26359933}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Platelet activation - Homo sapiens (human);Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- 0.305
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.24
Haploinsufficiency Scores
- pHI
- 0.171
- hipred
- Y
- hipred_score
- 0.652
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.813
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fermt3
- Phenotype
- digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- fermt3b
- Affected structure
- intersegmental vessel
- Phenotype tag
- abnormal
- Phenotype quality
- non-functional
Gene ontology
- Biological process
- platelet degranulation;leukocyte cell-cell adhesion;integrin-mediated signaling pathway;positive regulation of cell migration;integrin activation;regulation of cell-cell adhesion mediated by integrin;substrate adhesion-dependent cell spreading;platelet aggregation
- Cellular component
- podosome;extracellular region;membrane;cell junction;platelet alpha granule lumen;cell projection;extracellular exosome
- Molecular function
- integrin binding